UBS AM’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-142,131
| Closed | -$497K | – | 2689 |
|
2024
Q3 | $497K | Sell |
142,131
-46,329
| -25% | -$162K | ﹤0.01% | 2648 |
|
2024
Q2 | $618K | Buy |
+188,460
| New | +$618K | ﹤0.01% | 2568 |
|
2023
Q4 | – | Sell |
-35,408
| Closed | -$75.1K | – | 2564 |
|
2023
Q3 | $75.1K | Hold |
35,408
| – | – | ﹤0.01% | 2573 |
|
2023
Q2 | $202K | Hold |
35,408
| – | – | ﹤0.01% | 2568 |
|
2023
Q1 | $202K | Sell |
35,408
-42,743
| -55% | -$244K | ﹤0.01% | 2568 |
|
2022
Q4 | $789K | Sell |
78,151
-332,742
| -81% | -$3.36M | ﹤0.01% | 1970 |
|
2022
Q3 | $9.21M | Sell |
410,893
-103,204
| -20% | -$2.31M | 0.01% | 988 |
|
2022
Q2 | $12.7M | Buy |
514,097
+70,047
| +16% | +$1.74M | 0.01% | 872 |
|
2022
Q1 | $17.2M | Buy |
444,050
+16,707
| +4% | +$648K | 0.01% | 880 |
|
2021
Q4 | $25M | Buy |
427,343
+67,934
| +19% | +$3.97M | 0.01% | 845 |
|
2021
Q3 | $21.3M | Buy |
359,409
+15,842
| +5% | +$939K | 0.01% | 846 |
|
2021
Q2 | $29.8M | Buy |
343,567
+43,974
| +15% | +$3.82M | 0.01% | 781 |
|
2021
Q1 | $24.7M | Sell |
299,593
-110,832
| -27% | -$9.14M | 0.01% | 808 |
|
2020
Q4 | $37.3M | Sell |
410,425
-157,111
| -28% | -$14.3M | 0.02% | 682 |
|
2020
Q3 | $22.7M | Buy |
567,536
+10,462
| +2% | +$418K | 0.01% | 732 |
|
2020
Q2 | $19.1M | Buy |
557,074
+190,517
| +52% | +$6.54M | 0.01% | 754 |
|
2020
Q1 | $8.14M | Sell |
366,557
-184,939
| -34% | -$4.11M | 0.01% | 913 |
|
2019
Q4 | $10.8M | Buy |
551,496
+220
| +0% | +$4.31K | 0.01% | 918 |
|
2019
Q3 | $8.56M | Buy |
551,276
+12,345
| +2% | +$192K | 0.01% | 1007 |
|
2019
Q2 | $10.9M | Buy |
538,931
+7,230
| +1% | +$147K | 0.01% | 928 |
|
2019
Q1 | $9.34M | Buy |
531,701
+18,197
| +4% | +$320K | 0.01% | 951 |
|
2018
Q4 | $6.59M | Buy |
513,504
+447,726
| +681% | +$5.74M | 0.01% | 988 |
|
2018
Q3 | $1.07M | Buy |
+65,778
| New | +$1.07M | ﹤0.01% | 1784 |
|